SeekingAlphaAugust 12, 2026 at 7:45 AM NY2 Months Ago
Omada Health: Q2 Shows More Evidence Of Growth Converting Into Earnings
Omada Health (OMDA) delivered strong Q2 results, with 43% revenue growth, margin expansion, and positive adj. EBITDA, reinforcing my buy rating.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: SeekingAlpha
